Old Web
English
Sign In
Acemap
>
authorDetail
>
D. Matulich
D. Matulich
Cornell University
Medicine
Pathology
Chemotherapy
Oncology
Internal medicine
5
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981.
2011
American Journal of Clinical Oncology
Scott T. Tagawa
Matthew I. Milowsky
S. Jeske
Madhu Mazumdar
Sophia Kung
Max W. Sung
D. Lehrer
D. Matulich
Jodi Selzer
John J. Wright
David M. Nanus
Show All
Source
Cite
Save
Citations (10)
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 in patients (pts) with metastatic castration-resistant prostate cancer (metCRPC)
2009
Journal of Clinical Oncology
Scott T. Tagawa
S Parmar
J. Pena
K. Petrillo
D. Matulich
Jodi Selzer
Shankar Vallabhajosula
Stanley J. Goldsmith
Neil H. Bander
David M. Nanus
Show All
Source
Cite
Save
Citations (1)
Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu- J591) in patients (pts) with metastatic castrate-resistant prostate cancer (metCRPC)
2008
Journal of Clinical Oncology
Scott T. Tagawa
Matthew I. Milowsky
Michael J. Morris
Shankar Vallabhajosula
Stanley J. Goldsmith
D. Matulich
J. Kaplan
F. Berger
Howard I. Scher
Neil H. Bander
David M. Nanus
Show All
Source
Cite
Save
Citations (33)
Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981)
2008
Journal of Clinical Oncology
S. Jeske
Scott T. Tagawa
Matthew I. Milowsky
D. Matulich
S Kung
Max W. Sung
D. Lehrer
J. Kaplan
David M. Nanus
Show All
Source
Cite
Save
Citations (2)
1